Physiological and pharmacological roles of ABCG2 (BCRP): Recent findings in Abcg2 knockout mice

Advanced Drug Delivery Reviews

Volumn 61, Issue 1, 2009, Pages 14-25

  Vlaming, Maria L H ^a   Lagas, Jurjen S ^a   Schinkel, Alfred H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

BCRP Bcrp1; Blood brain barrier; Blood placental barrier; Blood retinal barrier; Blood testis barrier; Harderian gland; Mammary gland; Phytoestrogens; Porphyrins; Vitamin transport

Indexed keywords

BCRP/BCRP1; BLOOD-BRAIN BARRIER; BLOOD-PLACENTAL BARRIER; BLOOD-RETINAL BARRIER; BLOOD-TESTIS BARRIER; HARDERIAN GLAND; MAMMARY GLAND; PHYTOESTROGENS; VITAMIN TRANSPORT;

BIOCHEMISTRY; BIOLOGICAL MEMBRANES; CYTOLOGY; OPHTHALMOLOGY; PHYSIOLOGY; PORPHYRINS; PROBABILITY DENSITY FUNCTION; VITAMINS;

BLOOD;

ANTICONVULSIVE AGENT; BIOTIN; BREAST CANCER RESISTANCE PROTEIN; CEPHALOSPORIN; COUMESTROL; DAIDZEIN; DANTROLENE; FARNOQUINONE; FOLIC ACID; GENISTEIN; GLYCOPROTEIN P; IMATINIB; MENADIONE; MITOXANTRONE; OVALBUMIN; PANTOPRAZOLE; PHYTOMENADIONE; PORPHYRIN; PORPHYRIN DERIVATIVE; PRASTERONE SULFATE; PRAZOSIN; PROTOPORPHYRIN; QUERCETIN; RESVERATROL; RIBOFLAVIN; SULFANILAMIDE DERIVATIVE; TOPOTECAN; UNINDEXED DRUG; VITAMIN K GROUP; XENOBIOTIC AGENT;

BLOOD BRAIN BARRIER; BLOOD PLACENTA BARRIER; BLOOD TESTIS BARRIER; BREAST MILK; CONTINUOUS INFUSION; DRUG PENETRATION; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; XENOBIOTIC METABOLISM;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; HARDERIAN GLAND; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MICE; MICE, KNOCKOUT; MILK; MILK, HUMAN; NEOPLASM PROTEINS; PHYTOESTROGENS; PORPHYRINS; VITAMINS; XENOBIOTICS;

EID: 59049084011     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2008.08.007     Document Type: Review

References (67)

1. Hardwick L.J., Velamakanni S., and van Veen H.W. The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2). Br. J. Pharmacol. 151 (2007) 163-174
2. van Herwaarden A.E., and Schinkel A.H. The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins. Trends Pharmacol. Sci. 27 (2006) 10-16
3. Polgar O., Robey R.W., and Bates S.E. ABCG2: structure, function and role in drug response. Expert Opin. Drug Metab. Toxicol. 4 (2008) 1-15
4. Mao Q. BCRP/ABCG2 in the placenta: expression, function and regulation. Pharm. Res. 25 (2008) 1244-1255
5. Enokizono J., Kusuhara H., Ose A., Schinkel A.H., and Sugiyama Y. Quantitative investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) in limiting brain and testis penetration of xenobiotic compounds. Drug Metab. Dispos. 36 (2008) 995-1002
6. Jonker J.W., Merino G., Musters S., van Herwaarden A.E., Bolscher E., Wagenaar E., Mesman E., Dale T.C., and Schinkel A.H. The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat. Med. 11 (2005) 127-129
7. Jonker J.W., Buitelaar M., Wagenaar E., van der Valk M.A., Scheffer G.L., Scheper R.J., Plosch T., Kuipers F., Oude Elferink R.P., Rosing H., Beijnen J.H., and Schinkel A.H. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 15649-15654
8. Zhou S., Morris J.J., Barnes Y., Lan L., Schuetz J.D., and Sorrentino B.P. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 12339-12344
9. Schinkel A.H., Smit J.J., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., Mol C.A., Van Der Valk M.A., Robanus-Maandag E.C., te Riele H.P., Berns A.J., and Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77 (1994) 491-502
10. Schinkel A.H., Wagenaar E., Mol C.A., and van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest. 97 (1996) 2517-2524
11. Cooray H.C., Blackmore C.G., Maskell L., and Barrand M.A. Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport 13 (2002) 2059-2063
12. Eisenblatter T., Huwel S., and Galla H.J. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier. Brain Res. 971 (2003) 221-231
13. Doyle L.A., and Ross D.D. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22 (2003) 7340-7358
14. Lee Y.J., Kusuhara H., Jonker J.W., Schinkel A.H., and Sugiyama Y. Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein. J. Pharmacol. Exp. Ther. 312 (2005) 44-52
15. Yousif S., Marie-Claire C., Roux F., Scherrmann J.M., and Decleves X. Expression of drug transporters at the blood-brain barrier using an optimized isolated rat brain microvessel strategy. Brain Res. 1134 (2007) 1-11
16. Cisternino S., Mercier C., Bourasset F., Roux F., and Scherrmann J.M. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. Cancer Res. 64 (2004) 3296-3301
17. Soontornmalai A., Vlaming M.L., and Fritschy J.M. Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier. Neuroscience 138 (2006) 159-169
18. Breedveld P., Pluim D., Cipriani G., Wielinga P., van Tellingen O., Schinkel A.H., and Schellens J.H. The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients. Cancer Res. 65 (2005) 2577-2582
19. Hamada A., Miyano H., Watanabe H., and Saito H. Interaction of imatinib mesylate with human P-glycoprotein. J. Pharmacol. Exp. Ther. 307 (2003) 824-828
20. Dai H., Marbach P., Lemaire M., Hayes M., and Elmquist W.F. Distribution of STI-571 to the brain is limited by P-glycoprotein-mediated efflux. J. Pharmacol. Exp. Ther. 304 (2003) 1085-1092
21. Bihorel S., Camenisch G., Lemaire M., and Scherrmann J.M. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier. J. Neurochem. 102 (2007) 1749-1757
22. Enokizono J., Kusuhara H., and Sugiyama Y. Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Mol. Pharmacol. 72 (2007) 967-975
23. Jonker J.W., Freeman J., Bolscher E., Musters S., Alvi A.J., Titley I., Schinkel A.H., and Dale T.C. Contribution of the ABC transporters Bcrp1 and Mdr1a/1b to the side population phenotype in mammary gland and bone marrow of mice. Stem Cells 23 (2005) 1059-1065
24. de Vries N.A., Zhao J., Kroon E., Buckle T., Beijnen J.H., and van Tellingen O. P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan. Clin. Cancer Res. 13 (2007) 6440-6449
25. Jonker J.W., Smit J.W., Brinkhuis R.F., Maliepaard M., Beijnen J.H., Schellens J.H., and Schinkel A.H. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J. Natl. Cancer Inst. 92 (2000) 1651-1656
26. Oostendorp R.L., Buckle T., Beijnen J.H., van Tellingen O., and Schellens J.H. The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib. Invest. New Drugs 27 (2009) 31-40
27. Takenaka K., Morgan J.A., Scheffer G.L., Adachi M., Stewart C.F., Sun D., Leggas M., Ejendal K.F., Hrycyna C.A., and Schuetz J.D. Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution. Cancer Res. 67 (2007) 6965-6972
28. Kalabis G.M., Petropoulos S., Gibb W., and Matthews S.G. Breast cancer resistance protein (Bcrp1/Abcg2) in mouse placenta and yolk sac: ontogeny and its regulation by progesterone. Placenta 28 (2007) 1073-1081
29. Zhang Y., Wang H., Unadkat J.D., and Mao Q. Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse. Drug Metab. Dispos. 35 (2007) 2154-2158
30. Zhou L., Naraharisetti S.B., Wang H., Unadkat J.D., Hebert M.F., and Mao Q. The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Mol. Pharmacol. 73 (2008) 949-959
31. Gedeon C., Anger G., Piquette-Miller M., and Koren G. Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta. Placenta 29 (2008) 39-43
32. Pollex E., Lubetsky A., and Koren G. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta. Placenta 29 (2008) 743-747
33. Aleksunes L.M., Cui Y., and Klaassen C.D. Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared to placenta. Drug Metab. Dispos. 36 (2008) 1960-1970
34. Yeboah D., Kalabis G.M., Sun M., Ou R.C., Matthews S.G., and Gibb W. Expression and localisation of breast cancer resistance protein (BCRP) in human fetal membranes and decidua and the influence of labour at term. Reprod. Fertil. Dev. 20 (2008) 328-334
35. Holash J.A., Harik S.I., Perry G., and Stewart P.A. Barrier properties of testis microvessels. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 11069-11073
36. Dym M., and Fawcett D.W. The blood-testis barrier in the rat and the physiological compartmentation of the seminiferous epithelium. Biol. Reprod. 3 (1970) 308-326
37. Bart J., Hollema H., Groen H.J., de Vries E.G., Hendrikse N.H., Sleijfer D.T., Wegman T.D., Vaalburg W., and van der Graaf W.T. The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours. Eur. J. Cancer 40 (2004) 2064-2070
38. Wijnholds J., Scheffer G.L., van der Valk M., van der Valk P., Beijnen J.H., Scheper R.J., and Borst P. Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage. J. Exp. Med. 188 (1998) 797-808
39. Cooke H.J., and Saunders P.T. Mouse models of male infertility. Nat. Rev. Genet. 3 (2002) 790-801
40. Jones R.C. To store or mature spermatozoa? The primary role of the epididymis. Int. J. Androl. 22 (1999) 57-67
41. Sesink A.L., Arts I.C., de Boer V.C., Breedveld P., Schellens J.H., Hollman P.C., and Russel F.G. Breast cancer resistance protein (Bcrp1/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides. Mol. Pharmacol. 67 (2005) 1999-2006
42. Breedveld P., Pluim D., Cipriani G., Dahlhaus F., van Eijndhoven M.A., de Wolf C.J., Kuil A., Beijnen J.H., Scheffer G.L., Jansen G., Borst P., and Schellens J.H. The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport models. Mol. Pharmacol. 71 (2007) 240-249
43. Kyselova V., Peknicova J., Boubelik M., and Buckiova D. Body and organ weight, sperm acrosomal status and reproduction after genistein and diethylstilbestrol treatment of CD1 mice in a multigenerational study. Theriogenology 61 (2004) 1307-1325
44. Adeoya-Osiguwa S.A., Markoulaki S., Pocock V., Milligan S.R., and Fraser L.R. 17beta-Estradiol and environmental estrogens significantly affect mammalian sperm function. Hum. Reprod. 18 (2003) 100-107
45. Pulido M.M., Molina A.J., Merino G., Mendoza G., Prieto J.G., and Alvarez A.I. Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep. J. Vet. Pharmacol. Ther. 29 (2006) 279-287
46. van Herwaarden A.E., Wagenaar E., Merino G., Jonker J.W., Rosing H., Beijnen J.H., and Schinkel A.H. Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk. Mol. Cell. Biol. 27 (2007) 1247-1253
47. Powers H.J. Riboflavin (vitamin B-2) and health. Am. J. Clin. Nutr. 77 (2003) 1352-1360
48. Foraker A.B., Khantwal C.M., and Swaan P.W. Current perspectives on the cellular uptake and trafficking of riboflavin. Adv. Drug Deliv. Rev. 55 (2003) 1467-1483
49. Said H.M. Biotin: the forgotten vitamin. Am. J. Clin. Nutr. 75 (2002) 179-180
50. Zhou S., Zong Y., Ney P.A., Nair G., Stewart C.F., and Sorrentino B.P. Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels. Blood 105 (2005) 2571-2576
51. Jonker J.W., Musters S., Vlaming M.L., Plosch T., Gooijert K.E., Hillebrand M.J., Rosing H., Beijnen J.H., Verkade H.J., and Schinkel A.H. Breast cancer resistance protein (Bcrp1/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IX. Am. J. Physiol. Cell Physiol. 292 (2007) C2204-C2212
52. Krishnamurthy P., Ross D.D., Nakanishi T., Bailey-Dell K., Zhou S., Mercer K.E., Sarkadi B., Sorrentino B.P., and Schuetz J.D. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J. Biol. Chem. 279 (2004) 24218-24225
53. Assaraf Y.G. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis. Drug Resist. Updat. 9 (2006) 227-246
54. Shukla S., Wu C.P., Nandigama K., and Ambudkar S.V. The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance linked ATP binding cassette drug transporter ABCG2. Mol. Cancer Ther. 6 (2007) 3279-3286
55. Shearer M.J. Vitamin K. Lancet 345 (1995) 229-234
56. Merino G., van Herwaarden A.E., Wagenaar E., Jonker J.W., and Schinkel A.H. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver. Mol. Pharmacol. 67 (2005) 1765-1771
57. Merino G., Jonker J.W., Wagenaar E., van Herwaarden A.E., and Schinkel A.H. The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin. Mol. Pharmacol. 67 (2005) 1758-1764
58. Urquhart B.L., Tirona R.G., and Kim R.B. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J. Clin. Pharmacol. 47 (2007) 566-578
59. Verhasselt V., Milcent V., Cazareth J., Kanda A., Fleury S., Dombrowicz D., Glaichenhaus N., and Julia V. Breast milk-mediated transfer of an antigen induces tolerance and protection from allergic asthma. Nat. Med. 14 (2008) 170-175
60. Greenberger P.A. 8. Drug allergy. J. Allergy Clin. Immunol. 117 2 Suppl. Mini-Primer (2006) S464-470
61. Schwarz A. Pathology of allergic diseases. Acta Univ. Carol. Med. Monogr. 129 (1989) 1-197
62. Bohan K.H., Mansuri T.F., and Wilson N.M. Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care. Pharmacotherapy 27 (2007) 1425-1439
63. Payne A.P. The harderian gland: a tercentennial review. J. Anat. 185 Pt 1 (1994) 1-49
64. Krishnamurthy P., Xie T., and Schuetz J.D. The role of transporters in cellular heme and porphyrin homeostasis. Pharmacol. Ther. 114 (2007) 345-358
65. Asashima T., Hori S., Ohtsuki S., Tachikawa M., Watanabe M., Mukai C., Kitagaki S., Miyakoshi N., and Terasaki T. ATP-binding cassette transporter G2 mediates the efflux of phototoxins on the luminal membrane of retinal capillary endothelial cells. Pharm. Res. 23 (2006) 1235-1242
66. Boulton M., Rozanowska M., and Rozanowski B. Retinal photodamage. J. Photochem. Photobiol. B. 64 (2001) 144-161
67. Maliepaard M., Scheffer G.L., Faneyte I.F., van Gastelen M.A., Pijnenborg A.C., Schinkel A.H., van de Vijver M.J., Scheper R.J., and Schellens J.H. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 61 (2001) 3458-3464